GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bumrungrad Hospital PCL (BKK:BH) » Definitions » PE Ratio without NRI

Bumrungrad Hospital PCL (BKK:BH) PE Ratio without NRI

: 36.17 (As of Today)
View and export this data going back to 1989. Start your Free Trial

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2024-04-23), Bumrungrad Hospital PCL's share price is ฿225.00. Bumrungrad Hospital PCL's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ฿6.22. Therefore, Bumrungrad Hospital PCL's PE Ratio without NRI for today is 36.17.

During the past 13 years, Bumrungrad Hospital PCL's highest PE Ratio without NRI was 225.47. The lowest was 25.82. And the median was 43.95.

Bumrungrad Hospital PCL's EPS without NRI for the three months ended in Dec. 2023 was ฿1.97. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ฿6.22.

As of today (2024-04-23), Bumrungrad Hospital PCL's share price is ฿225.00. Bumrungrad Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ฿6.25. Therefore, Bumrungrad Hospital PCL's PE Ratio for today is 36.00.

Good Sign:

Bumrungrad Hospital PCL stock PE Ratio (=28.09) is close to 10-year low of 25.93

During the past years, Bumrungrad Hospital PCL's highest PE Ratio was 229.84. The lowest was 24.11. And the median was 43.84.

Bumrungrad Hospital PCL's EPS (Diluted) for the three months ended in Dec. 2023 was ฿1.99. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ฿6.25.

Bumrungrad Hospital PCL's EPS (Basic) for the three months ended in Dec. 2023 was ฿2.16. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was ฿6.82.


Bumrungrad Hospital PCL PE Ratio without NRI Historical Data

The historical data trend for Bumrungrad Hospital PCL's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bumrungrad Hospital PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.89 86.64 96.77 37.24 27.56

Bumrungrad Hospital PCL Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PE Ratio without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.24 46.57 40.92 44.38 27.56

Competitive Comparison

For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bumrungrad Hospital PCL PE Ratio without NRI Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Bumrungrad Hospital PCL's PE Ratio without NRI falls into.



Bumrungrad Hospital PCL PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Bumrungrad Hospital PCL's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=225.00/6.221
=36.17

Bumrungrad Hospital PCL's Share Price of today is ฿225.00.
Bumrungrad Hospital PCL's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿6.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Bumrungrad Hospital PCL  (BKK:BH) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Bumrungrad Hospital PCL PE Ratio without NRI Related Terms

Thank you for viewing the detailed overview of Bumrungrad Hospital PCL's PE Ratio without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Bumrungrad Hospital PCL (BKK:BH) Business Description

Traded in Other Exchanges
Address
33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. It is a healthcare provider in Thailand and the Southeast Asian region, providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities, both within and outside of Thailand. It includes Bumrungrad International Hospital, Bumrungrad International Clinic, Bumrungrad International Laboratory Clinic, Vitallife Scientific Wellness Center, Vitallife Skin Clinic, Bumrungrad International Dialysis Clinic, and Esperance Cancer Clinic, all are in Bangkok; Bumrungrad Clinic Yangon in Myanmar, and Ulaanbaatar Songdo Hospital in Mongolia.

Bumrungrad Hospital PCL (BKK:BH) Headlines

From GuruFocus

Biglari Holdings Inc. News Release

By PRNewswire PRNewswire 08-05-2022

BIGLARI HOLDINGS INC. NEWS RELEASE

By PRNewswire 11-03-2023

Biglari Holdings Inc. News Release

By PRNewswire PRNewswire 11-05-2021

Biglari Holdings Inc (BH) Chairman and CEO Sardar Biglari, Bought $746,397 of Shares

By GuruFocus Research GuruFocus Editor 06-15-2021

Biglari Holdings Inc. News Release

By PRNewswire PRNewswire 05-07-2021

BIGLARI HOLDINGS INC. NEWS RELEASE

By PRNewswire PRNewswire 02-25-2023

Biglari Holdings Inc. News Release

By PRNewswire PRNewswire 07-05-2022

Biglari Holdings Inc. News Release

By PRNewswire PRNewswire 06-25-2022